Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.

Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.
复制标题

DOI:
10.1038/onc.2009.73
复制
发表时间:
2009-05-21
期刊:
影响因子:
8
通讯作者:
Collins VP
Collins VP
中科院分区:
医学1区
文献类型:
--
作者:
Jones DT;Kocialkowski S;Liu L;Pearson DM;Ichimura K;Collins VP

文献摘要

参考文献

被引文献

相似文献

毛细胞星形细胞瘤(PAs)是世卫组织一级恶性肿瘤,是5-19岁儿童中最常见的中枢神经系统肿瘤。最近的报道强调了PAs中MAPK通路激活的重要性,特别是通过串联复制导致致癌BRAF融合基因。在这里,我们报告了导致PAs中MAPK激活的两种可选机制。首先,与常见的BRAF融合惊人的相似,在3p25处观察到串联重复,这在SRGAP3和RAF1之间产生了框架内的致癌融合。这种融合包括Raf1激酶结构域,与野生型Raf1相比,显示出更高的激酶活性。其次,BRAF密码子598处一个新的3bp插入模仿热点V600E突变,产生一个转化的、组成活性的BRAF激酶。虽然这两种改变并不常见,但它们使Ras/Raf信号通路被“击中”的病例数量从我们的44例(82%)增加到36例,证实了其对毛细胞星形细胞瘤发展的核心重要性。
Pilocytic astrocytomas (PAs), WHO malignancy grade I, are the most frequently occurring central nervous system tumour in 5-19 year-olds. Recent reports have highlighted the importance of MAPK pathway activation in PAs, particularly through a tandem duplication leading to an oncogenic BRAF fusion gene. Here we report two alternative mechanisms resulting in MAPK activation in PAs. Firstly, in striking similarity to the common BRAF fusion, a tandem duplication at 3p25 was observed, which produces an in-frame oncogenic fusion between SRGAP3 and RAF1. This fusion includes the Raf1 kinase domain, and shows elevated kinase activity when compared with wild-type Raf1. Secondly, a novel 3bp insertion at codon 598 in BRAF mimics the hotspot V600E mutation to produce a transforming, constitutively active BRaf kinase. Whilst these two alterations are not common, they bring the number of cases with an identified ‘hit’ on the Ras/Raf signalling pathway to 36 from our series of 44 (82%), confirming its central importance to the development of pilocytic astrocytomas.
DOI: 10.1016/j.febslet.2005.11.078
发表时间: 2006-01-09
期刊: FEBS LETTERS
影响因子: 3.5
作者:
Icking, A;Schilling, K;M端ller-Esterl, W
通讯作者: M端ller-Esterl, W
DOI: 10.1177/088307389400900317
发表时间: 1994-07-01
影响因子: 1.9
作者:
TOMLINSON, FH;SCHEITHAUER, BW;JACK, CR
通讯作者: JACK, CR
DOI: 10.1055/s-2007-984451
发表时间: 2007-04-01
期刊: NEUROPEDIATRICS
影响因子: 1.4
作者:
Janzarik, W. G.;Kratz, C. P.;Omran, H.
通讯作者: Omran, H.
DOI: 10.1126/science.6691137
发表时间: 1984-01-01
期刊: SCIENCE
影响因子: 56.9
作者:
BONNER, T;OBRIEN, SJ;LEDER, P
通讯作者: LEDER, P
DOI: 10.1007/s003810050033
发表时间: 1997-01-01
影响因子: 1.4
作者:
Dirven, CMF;Mooij, JJA;Molenaar, WM
通讯作者: Molenaar, WM